Laidlaw & Company Experiences Legal Issues Stemming from its Relationship with Relmada Therapeutics Inc.

When a company contracts the services of another company, it is imperative for the contracted company to honor the terms and conditions of the agreement. Breaching corporate agreements can trigger legal feuds such as the one witnessed between Relmada Therapeutics and Laidlaw. The PR Newswire article posted on January 26, 2016, gives an insight into the kind of issues that stem out of corporate legal battles.

Relmada’s motion in the District Court for the District of Nevada marked part of its previously filed lawsuit. The first complaint had led to a temporary restraining order issued by the District of Nevada Court against Laidlaw and its key executives James Ahern and Matthew Eitner for breaching fiduciary duty.

Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern

The new complaint consists of an additional claim pertaining Laidlaw & Company’s violation of fiduciary duty. Relmada accused Laidlaw of disclosing confidential details acquired on its behalf while serving as Relmada’s investment banker. Further, the amended complainant also included a monetary damages claim for expenses incurred by Relmada in countering the misleading and false information released by Laidlaw in December 2015.

Laidlaw & Company

The Laidlaw & Company boasts of a legacy that spans more than 170 years in securities brokerage and investment banking matters. Its full-service brokerage and investment banking services target numerous clients including private clients, corporate entrepreneurs, as well as international and domestic firms or companies. Laidlaw‘s capital market and investment banking strategy include natural resources, mining, and metals.

Laidlaw boasts of a growing network of branches or offices in various parts of the world such as Europe and the United States. It leverages the expertise and vast experience of its team of professionals who are FINRA registered and authorized by FCA. Further, it includes an expanded investment strategy that comprises late stage private securities in Twitter, Facebook, and LinkedIn. Laidlaw’s executive team includes Matthew Eitner, the company’s Chief Executive Officer, and James Ahern, the Managing Partner as well as the Head of Capital Strategy.

Leave a Reply

Your email address will not be published. Required fields are marked *